John Hoekman
Chief Scientific Officer, Impel Neuropharma (United States).
Companies
- Impel Neuropharma (United States)Chief Scientific Officer Apr 22, 2021 to Feb 16, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Impel Neuropharma (United States)128,221 shares2Dec 22, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 22, 2021Exercised options 20,000 shares at $1.64 of Impel Neuropharma (United States)2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2